Literature DB >> 29749567

Ocular surface squamous neoplasia: analysis based on the 8th American Joint Committee on Cancer classification.

Swati Singh1, Ashik Mohamed2, Swathi Kaliki3.   

Abstract

PURPOSE: To evaluate outcomes of ocular surface squamous neoplasia (OSSN) based on American Joint Committee on Cancer (AJCC), 8th edition classification.
METHODS: Retrospective, non-randomized interventional case series of 127 patients (136 eyes) with OSSN.
RESULTS: On the basis of the AJCC (eighth edition), OSSN was classified as per T category as Tis (n = 14, 10%), T1 (n = 0), T2 (n = 4, 3%), T3 (n = 113, 83%), and T4 (n = 5, 4%). The following parameters increased with increasing T category: mean age at presentation at 37 years for Tis, 43 years for T2, 46 years for T3, and 55 years for T4 (p = 0.04); mean tumor basal diameter of 4 mm for Tis, not applicable (na) for T1, 6 mm for T2, 7 mm for T3, 20 mm for T4 (p = 0.001); extent of clock hours of corneal involvement (0, na, 0, 4, 8; p = 0.02), and conjunctival involvement (1, na, 2, 3, 9; p = 0.0005); involvement of adjacent structures including fornix (0%, na, 0, 9, 80%; p < 0.001), and caruncle (0%, na, 0, 3, 60%; p < 0.001) for Tis, T1, T2, T3, and T4, respectively. Overall, of the 136 eyes, 19 (14%) had tumor recurrence, and all tumor recurrences were seen in T3. Regional lymph node metastasis was noted in 4 (3%) patients. No systemic metastasis or death occurred in any patient during the mean follow-up period of 15 months (median, 11 months; range 6-55 months).
CONCLUSION: Increasing T category based on AJCC 8th edition classification is associated with increasing severity of disease, tumor recurrence rate, and the rate of regional lymph node metastasis.

Entities:  

Keywords:  Eye; Eye neoplasms; Local neoplasm recurrence; Neoplasm staging; Squamous cell neoplasms

Mesh:

Year:  2018        PMID: 29749567     DOI: 10.1007/s10792-018-0943-x

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

1.  Determining tumor category of ocular surface squamous neoplasia: science or art?

Authors:  Curtis E Margo; Norberto Mancera
Journal:  Ann Transl Med       Date:  2018-12

2.  Update on the Management of Ocular Surface Squamous Neoplasia.

Authors:  Umangi Patel; Carol L Karp; Sander R Dubovy
Journal:  Curr Ophthalmol Rep       Date:  2021-02-20

3.  Management Issues in Conjunctival Tumours: Ocular Surface Squamous Neoplasia.

Authors:  Victoria M L Cohen; Roderick F O'Day
Journal:  Ophthalmol Ther       Date:  2019-11-23

4.  Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis.

Authors:  Kincső Kozma; Zsuzsa Réka Dömötör; Adrienne Csutak; László Szabó; Péter Hegyi; Bálint Erőss; Zsuzsanna Helyes; Zsolt Molnár; Fanni Dembrovszky; Eszter Szalai
Journal:  Sci Rep       Date:  2022-08-20       Impact factor: 4.996

Review 5.  Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence.

Authors:  Maria Vittoria Cicinelli; Alessandro Marchese; Francesco Bandello; Giulio Modorati
Journal:  Ophthalmol Ther       Date:  2018-07-20

6.  Squamous cell carcinoma of the lacrimal punctum: A rare presentation.

Authors:  Akshay Gopinathan Nair; Indumati Gopinathan; Vandana Jain
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.